LeplusCyto Trademark Information
Number:
2615627
Words:
LeplusCyto
Kind:
Word
Status group:
PENDING
Status code:
Accepted
Status detail:
In opposition period
Priority date:
16 Jan 2026
Lodgement date:
16 Jan 2026
First report date:
02 Feb 2026
Acceptance date:
02 Feb 2026
Acceptance advertised date:
17 Jun 2026
Filing date:
16 Jan 2026
Indexing constituents:
LEPLUSCYTO, LEPLUS, CYTOClass:
1,5
Mark categories:
Trademark
Last status check:
2026-06-28 15:45:17
Status updated at:
2026-06-19 21:38:18
Goods and services:
1) Class: 1Description: vitamins for use in the manufacture of food supplements, vitamins for use in the manufacture of dietary supplements, proteins used in the manufacture of food supplements, proteins for use in the manufacture of food supplements, chemical preparations for use in the manufacture of pharmaceuticals, active chemical agents for the manufacture of pharmaceuticals, vitamins for use in the manufacture of pharmaceuticals, chemicals for use in biotechnological product development
2) Class: 5
Description: food supplements, dietary supplements, dietary and nutritional supplements, nutritional supplements, mineral supplements, vitamin supplements, food supplements for medical use, food supplements for medical purposes, nutritional and food supplements, dietary supplements for medical use, dietary supplements for medical purposes, healthcare preparations and supplements, nutritional supplements for medical purposes, vitamin and mineral preparations for medical purposes, nutritional supplements for medical use, dietary supplements for pharmaceutical use, dietary supplements for pharmaceutical purposes, pharmaceutical and medical preparations, pharmaceutical substances and preparations, pharmaceutical drugs, chemical products for pharmaceutical purposes, medicinal substances and preparations, chemicals for medical use, chemical products for therapeutic use, drugs for medical purposes, pharmaceuticals, biotechnological preparations for medical use, biochemical medicines, biochemical drug, biochemical preparations for medical use, biomaterials in the nature of biological tissues for clinical purposes, biomaterials in the nature of biological tissues for medical purposes, biomaterials in the nature of biological tissue cells for clinical purposes, biomaterials in the nature of biological tissue cultures for medical purposes, biomaterials in the nature of biological tissue cells for medical purposes, bioinks in the nature of biological tissues for clinical purposes, bioinks in the nature of biological tissues for medical purposes, bioinks in the nature of biological tissue cultures for clinical purposes
History and publication details:
1) Date: 2026-06-17
Display name: Application Accepted correspondence sent
2) Date: 2026-06-17
Display name: IP Right has been Examined
3) Date: 2026-06-17
Display name: IP Right Acceptance Published
4) Date: 2026-02-02
Display name: Early Acceptance Notice correspondence sent
5) Date: 2026-02-02
Display name: Status change to Accepted
6) Date: 2026-01-19
Display name: IP Right Filed correspondence sent
7) Date: 2026-01-19
Display name: Examination expedited
8) Date: 2026-01-19
Display name: Awaiting examination
9) Date: 2026-01-19
Display name: IP Right Filed Published
10) Date: 2026-01-19
Display name: Status change to Published
11) Date: 2026-01-19
Display name: Status change to Filed
12) Date: 2026-01-19
Display name: Trade mark representation updated
13) Date: 2026-01-19
Display name: Application Received
Display name: Application Accepted correspondence sent
2) Date: 2026-06-17
Display name: IP Right has been Examined
3) Date: 2026-06-17
Display name: IP Right Acceptance Published
4) Date: 2026-02-02
Display name: Early Acceptance Notice correspondence sent
5) Date: 2026-02-02
Display name: Status change to Accepted
6) Date: 2026-01-19
Display name: IP Right Filed correspondence sent
7) Date: 2026-01-19
Display name: Examination expedited
8) Date: 2026-01-19
Display name: Awaiting examination
9) Date: 2026-01-19
Display name: IP Right Filed Published
10) Date: 2026-01-19
Display name: Status change to Published
11) Date: 2026-01-19
Display name: Status change to Filed
12) Date: 2026-01-19
Display name: Trade mark representation updated
13) Date: 2026-01-19
Display name: Application Received
Owner Information
Owner structured address:
49 Belmont Church Road, Belfast, UNITED KINGDOM, Postal Code: BT4 3FF
Owner is private:
0
Service Information
Address structured address:
U 1 13 Werambie St, Woolwich, NSW, AUSTRALIA, Postal Code: 2110
Address is private:
0